Pascal Touchon
Net worth: 712 384 $ as of 31/10/2026
Net worth: 712 384 $ as of 31/10/2026
Pascal Touchon is currently an Independent Director at MedinCell SA since 2025, a Director at Ipsen SA since 2023, and a Partner at Jeito Capital SASU starting in 2026.
Former roles include Chairman at Atara Biotherapeutics, Inc. from 2024 to 2025, and Director positions at Navigate BioPharma Services, Inc., Genoptix, Inc., Cogen Immune Medicine, Inc., Dantari, Inc., and Novartis Oncology, Inc. Education includes an MBA from INSEAD and a doctorate from Université Toulouse III - Paul Sabatier.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2025 | 77,955 ( 0.78% ) | 624 420 $ | 31/10/2026 | |
IPSEN SA 0% | 31/12/2025 | 500 ( 0% ) | 87 964 $ | 31/10/2026 |
| Companies | Position | Start |
|---|---|---|
| IPSEN | Director/Board Member | 01/10/2023 |
| MEDINCELL S.A. | Director/Board Member | 01/03/2025 |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Private Equity Investor | 01/06/2025 |
| Companies | Position | End |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Chief Executive Officer | 09/09/2024 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Director/Board Member | 01/02/2020 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | - |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Director/Board Member | - |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Finance |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions